How long after injecting Mounjaro does it start to work?

The question you're really asking: will I feel anything soon?

It's a fair thing to wonder. You've done the injection, you've put the pen in the sharps bin, and now you're watching your appetite waiting for something to shift. The honest answer is that the medicine starts its work at a receptor level faster than you feel it.

Tirzepatide is a dual GIP and GLP-1 receptor agonist. Once it's absorbed from the subcutaneous tissue (your abdomen, thigh or upper arm) it circulates and binds to receptors involved in appetite signalling and gastric emptying. That pharmacological activity starts within hours. What takes longer is the downstream behavioural effect: feeling less interested in finishing a large plate of food, noticing fullness arriving earlier, or simply not thinking about your next meal as urgently. For most people that shift becomes perceptible somewhere in the first one to two weeks, often around day five to ten of the first pen.

One quick, practical check: keep a brief note on your phone of how hungry you feel at your usual meal times during the first fortnight. Not a food diary, just a one-word rating. It takes under a minute and gives you a real reference point rather than relying on memory. People often underestimate how much has changed until they compare notes from week one with week four.

If nothing at all seems different by the end of the second week, that is worth discussing with your prescriber rather than adjusting anything yourself. You can reach our clinical team through the contact page any day of the week.

Why the first pen produces modest effects by design

The licensed starting dose for Mounjaro is 2.5 mg, and this choice is deliberate. Its job is not to produce the maximum appetite reduction, it is to let your body acclimatise to the medicine before the dose rises. Gastrointestinal side effects, principally nausea, are most likely to appear at the beginning of treatment or after a dose step-up, and starting low reduces that risk considerably. You can read more about the Mounjaro injection and how the pen is used at each stage of the schedule.

Most prescribers titrate the dose in roughly four-week steps: 2.5 mg, then 5 mg, then 7.5 mg, and so on, up to a maximum of 15 mg depending on your response and tolerance. Each step-up brings renewed activity at the receptors, which is why many people notice a fresh wave of appetite suppression after a dose increase. Weight loss consequently tends to accelerate as doses rise. The first injection's effects are real but incremental; expecting the same result as the maintenance dose would mean misreading what the schedule is for.

The broader SURMOUNT clinical programme showed that the most substantial average weight reductions appeared at the higher doses, over 12–18 months of treatment. That is not a reason to feel disheartened at 2.5 mg, it is a reason to stay consistent. The full Mounjaro overview covers what the trial evidence showed across the dose range.

What affects how quickly you personally notice the effects

Even within the expected window, individual responses vary. Several factors shape that variation. Injection technique matters more than people realise: the medicine needs to go into subcutaneous tissue, not muscle, and rotating sites consistently keeps absorption predictable. The guide to using the Mounjaro pen correctly covers site rotation and the injection steps that affect how reliably the dose is delivered.

What you eat alongside treatment also plays a role. Tirzepatide slows gastric emptying and alters appetite signalling, but a diet that is high in rapidly digested, calorie-dense foods can blunt the feeling of early fullness. Protein and fibre help; staying well hydrated helps. None of this replaces your prescriber's guidance, and your clinical team at nume, led by our clinical director, can discuss what to expect at each dose stage when you speak with them.

Side effects are sometimes the first sign that the medicine is active, and they tend to appear on a similar timeline to the appetite effects. If you want to understand the timing of Mounjaro's side effects alongside its benefits, that page covers the pattern in detail. The NHS's patient information for tirzepatide is also worth reading, the NHS tirzepatide page covers the common side effects and when to seek help.

When results feel slower than expected, and what actually matters

The honest reality is that some people notice significant changes in their first fortnight; others reach the end of the first pen feeling uncertain whether the medicine is doing anything. Both groups can go on to achieve substantial results over time. Week-by-week weight does not follow a straight line, water retention, hormonal cycles, dietary variation and many other factors create apparent plateaus that have nothing to do with whether tirzepatide is working.

SURMOUNT-1, the pivotal trial published in the New England Journal of Medicine, randomised 2,539 adults and tracked outcomes over 72 weeks. Average weight reductions at the 15 mg dose approached 21% of body weight, but those figures were built across the full duration. Early responders and slower responders ended up in very similar places by the end of the trial. The first four weeks are real but they are not predictive.

If you are considering starting treatment or wondering whether Mounjaro is right for your situation, the weight-loss treatments overview explains what private clinical assessment involves. Cost context for private prescriptions is covered separately on the Eli Lilly price increase page, which may be useful if you are comparing options. When you're ready to take the next step, start your free consultation and a GPhC-registered prescriber will review your details the same day.